| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9ea5e587ef25c062c68d34319647d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce4e9f31950bd10425873c8d586ac93b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e1f3b5e6cf6c41b7aeee3f79a65d3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1341f5148e813dedecfc3fd5bb13937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c8f89d6bc80e05ad1bbd74c9f62a3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef55e39a9db08580d92c2b3bc143951d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efda51f8d86078fb27818c679200c786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd886699d0e40c04af5f661b3105072d |
| publicationDate |
2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2009001021-A |
| titleOfInvention |
SPECIFIC UNION AGENTS DIRECTED TO PDGFR-ALFA AND ITS USES. |
| abstract |
Object binding agents directed to the PDGFR-alpha antigen and uses of such agents are described. More specifically the invention relates to fully human monoclonal antibodies directed to the PDGFR-alpha antigen and to uses of these antibodies. Aspects of the invention also relate to hybridomas or other cell lines that express such antibodies. The object binding agents and antibodies described are useful as a diagnosis and for the treatment of diseases associated with the activity and / or overexpression of PDGFR-alpha. |
| priorityDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |